TMZ reduces the release of proinflammatory mediators from macrophages induced by reactive oxygen species, including C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), interleukin 1 (IL-1), and interleukin 8 (IL-8) during both inflammation and ischemia [10]. The gene discussed is CXCL8; the disease is ischemia.